Literature DB >> 26867563

Lactobacillus acidophilus stimulates intestinal P-glycoprotein expression via a c-Fos/c-Jun-dependent mechanism in intestinal epithelial cells.

Shubha Priyamvada1, Arivarasu N Anbazhagan1, Anoop Kumar1, Vikas Soni1, Waddah A Alrefai2, Ravinder K Gill1, Pradeep K Dudeja2, Seema Saksena3.   

Abstract

Our previous studies showed that Lactobacillus acidophilus (LA) culture supernatant (CS) increased P-glycoprotein [Pgp/multidrug resistance 1 (MDR1)] function, expression, and promoter activity in Caco-2 cells. The current studies were designed to elucidate the molecular mechanisms mediating the stimulatory effects of LA CS on Pgp promoter activity. Deletion analysis indicated that the LA CS response element(s) is located in the -172/+428-bp region, and sequence analysis of this region revealed three potential binding sites for c-Fos or c-Jun: proximal activating protein (AP) 1a (-119/-98 bp), distal AP1b (-99/-78 bp), and AP1c (+175/+196 bp). LA CS (24 h) showed an approximately twofold increase in the protein expression of c-Fos and c-Jun in Caco-2 cells. Electrophoretic mobility shift assay showed that LA CS markedly increased the binding of Caco-2 nuclear proteins to AP1a and AP1b, but not AP1c. The DNA-protein complex was completely eliminated by c-Fos antibody, while c-Jun antibody partially eliminated the complex. Chromatin immunoprecipitation analysis also showed that LA CS enhanced the association of c-Fos and c-Jun (by ∼4- and 1.5-fold, respectively) with endogenous Pgp promoter in Caco-2 cells (p-172/+1). Interestingly, overexpression of c-Fos or c-Jun activated Pgp promoter by nearly twofold each. This increase was further enhanced (∼14-fold) when c-Fos and c-Jun were simultaneously overexpressed, suggesting that the presence of one of these transcription factors potentiates the effect of the other. These studies, for the first time, provide evidence for the involvement of c-Fos/c-Jun in stimulation of Pgp gene expression by LA CS in the human intestine.

Entities:  

Keywords:  Erk1/2 MAPK; activating protein 1; multidrug resistance 1 promoter; probiotics; transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 26867563      PMCID: PMC4836133          DOI: 10.1152/ajpgi.00210.2015

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  55 in total

1.  Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells.

Authors:  Yun Tao; Kenneth A Drabik; Tonya S Waypa; Mark W Musch; John C Alverdy; Olaf Schneewind; Eugene B Chang; Elaine O Petrof
Journal:  Am J Physiol Cell Physiol       Date:  2005-11-23       Impact factor: 4.249

Review 2.  Pharmacological regulation of AP-1 transcription factor DNA binding activity.

Authors:  K R Pennypacker; J S Hong; M K McMillian
Journal:  FASEB J       Date:  1994-05       Impact factor: 5.191

3.  Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.

Authors:  Seema Saksena; Sonia Goyal; Geetu Raheja; Varsha Singh; Maria Akhtar; Talat M Nazir; Waddah A Alrefai; Ravinder K Gill; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

4.  Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice.

Authors:  Hisashi Iizasa; Naomi Genda; Tomohide Kitano; Mikio Tomita; Kazuyo Nishihara; Masahiro Hayashi; Kayako Nakamura; Shizuko Kobayashi; Emi Nakashima
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

5.  Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels.

Authors:  Hans Blokzijl; Sara Vander Borght; Lisette I H Bok; Louis Libbrecht; Mariska Geuken; Fiona A J van den Heuvel; Gerard Dijkstra; Tania A D Roskams; Han Moshage; Peter L M Jansen; Klaas Nico Faber
Journal:  Inflamm Bowel Dis       Date:  2007-06       Impact factor: 5.325

6.  Recommendations for probiotic use-2011 update.

Authors:  Martin H Floch; W Allan Walker; Karen Madsen; Mary Ellen Sanders; George T Macfarlane; Harry J Flint; Levinus A Dieleman; Yehuda Ringel; Stefano Guandalini; Ciaran P Kelly; Lawrence J Brandt
Journal:  J Clin Gastroenterol       Date:  2011-11       Impact factor: 3.062

7.  Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor.

Authors:  Paula Monje; Maria Julia Marinissen; J Silvio Gutkind
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

Review 9.  Mechanisms of action of probiotics: recent advances.

Authors:  S C Ng; A L Hart; M A Kamm; A J Stagg; S C Knight
Journal:  Inflamm Bowel Dis       Date:  2009-02       Impact factor: 5.325

10.  Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

Authors:  D Guyonnet; O Chassany; P Ducrotte; C Picard; M Mouret; C-H Mercier; C Matuchansky
Journal:  Aliment Pharmacol Ther       Date:  2007-08-01       Impact factor: 8.171

View more
  5 in total

1.  Epigenetic modulation of intestinal Na+/H+ exchanger-3 expression.

Authors:  Anoop Kumar; Pooja Malhotra; Hayley Coffing; Shubha Priyamvada; Arivarasu N Anbazhagan; Harish R Krishnan; Ravinder K Gill; Waddah A Alrefai; David P Gavin; Subhash C Pandey; Pradeep K Dudeja; Seema Saksena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-11-22       Impact factor: 4.052

2.  Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.

Authors:  Hayley Coffing; Shubha Priyamvada; Arivarasu N Anbazhagan; Christine Salibay; Melinda Engevik; James Versalovic; Mary Beth Yacyshyn; Bruce Yacyshyn; Sangeeta Tyagi; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

3.  P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.

Authors:  Elke Cario
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

4.  Swine-Derived Probiotic Lactobacillus plantarum Modulates Porcine Intestinal Endogenous Host Defense Peptide Synthesis Through TLR2/MAPK/AP-1 Signaling Pathway.

Authors:  Jing Wang; Wei Zhang; Sixin Wang; Hui Liu; Dongyan Zhang; Yamin Wang; Haifeng Ji
Journal:  Front Immunol       Date:  2019-11-19       Impact factor: 7.561

5.  Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression.

Authors:  Sage E Foley; Michael J Dente; Xuqiu Lei; Benjamin F Sallis; Ethan B Loew; Mario Meza-Segura; Katherine A Fitzgerald; Beth A McCormick
Journal:  mBio       Date:  2022-08-15       Impact factor: 7.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.